A significantly larger proportion in the intervention ( 46 % ) vs control group ( 16 % ) fulfilled the Outcome Measures in Rheumatological Clinical Trials-Osteoarthritis Research Society International ( OMERACT-OARSI ) responder criteria at 3 months ( OR = 4.4 , 95 % CI 1.9 , 10.2 ) .